These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35674309)

  • 1. Application of Induced Pluripotent Stem Cells in Moyamoya Disease: Progress and Promises.
    Xue Y; Zhang Q; Wang LJ; Tu WJ; Zhao J
    Curr Stem Cell Res Ther; 2023; 18(6):733-739. PubMed ID: 35674309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Smooth Muscle Cell Derived from IPS Cell of Moyamoya Disease - Comparative Characterization with Endothelial Cell Transcriptome.
    Tokairin K; Hamauchi S; Ito M; Kazumata K; Sugiyama T; Nakayama N; Kawabori M; Osanai T; Houkin K
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105305. PubMed ID: 32992193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Progenitor Cells in Moyamoya Disease: Current Situation and Controversial Issues.
    Yu J; Du Q; Hu M; Zhang J; Chen J
    Cell Transplant; 2020; 29():963689720913259. PubMed ID: 32193953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in hemorrhagic moyamoya disease.
    Wan M; Duan L
    Br J Neurosurg; 2015 Apr; 29(2):189-91. PubMed ID: 25365664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on the diagnosis and treatment of adult Moyamoya disease taking into consideration controversial issues.
    Kim JE; Jeon JS
    Neurol Res; 2014 May; 36(5):407-16. PubMed ID: 24641716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of Securin by the variant RNF213 R4810K (rs112735431, G>A) reduces angiogenic activity of induced pluripotent stem cell-derived vascular endothelial cells from moyamoya patients.
    Hitomi T; Habu T; Kobayashi H; Okuda H; Harada KH; Osafune K; Taura D; Sone M; Asaka I; Ameku T; Watanabe A; Kasahara T; Sudo T; Shiota F; Hashikata H; Takagi Y; Morito D; Miyamoto S; Nakao K; Koizumi A
    Biochem Biophys Res Commun; 2013 Aug; 438(1):13-9. PubMed ID: 23850618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinolytic activity of autocrine matrix metalloproteinase-9 leads to endothelial de-arrangement in Moyamoya disease.
    Blecharz-Lang KG; Prinz V; Burek M; Frey D; Schenkel T; Krug SM; Fromm M; Vajkoczy P
    J Cereb Blood Flow Metab; 2018 Nov; 38(11):1940-1953. PubMed ID: 29633884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic Profiling of Exosomes From Hemorrhagic Moyamoya Disease and Dysfunction of Mitochondria in Endothelial Cells.
    Wang X; Han C; Jia Y; Wang J; Ge W; Duan L
    Stroke; 2021 Oct; 52(10):3351-3361. PubMed ID: 34334053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
    Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of circulating endothelial progenitor cells in patients with Moyamoya disease.
    Rafat N; Beck GCh; Peña-Tapia PG; Schmiedek P; Vajkoczy P
    Stroke; 2009 Feb; 40(2):432-8. PubMed ID: 19095988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research progress on moyamoya disease combined with thyroid diseases.
    Zhang G; Liu E; Tan X; Liu C; Yang S
    Front Endocrinol (Lausanne); 2023; 14():1233567. PubMed ID: 37900127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smooth-muscle progenitor cells isolated from patients with moyamoya disease: novel experimental cell model.
    Kang HS; Moon YJ; Kim YY; Park WY; Park AK; Wang KC; Kim JE; Phi JH; Lee JY; Kim SK
    J Neurosurg; 2014 Feb; 120(2):415-25. PubMed ID: 24160477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of an induced pluripotent stem cell line HUSTTJi001-A from a Moyamoya disease patient with RNF213 gene mutation.
    Mao Z; Li Y; Huang L; Chen Y; Luo H; Zhang S; Chen H
    Stem Cell Res; 2021 Dec; 57():102575. PubMed ID: 34749017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.
    Phi JH; Suzuki N; Moon YJ; Park AK; Wang KC; Lee JY; Choi SA; Chong S; Shirane R; Kim SK
    PLoS One; 2017; 12(1):e0169714. PubMed ID: 28072843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Precision Medicine for Moyamoya Disease].
    Fujimura M
    No Shinkei Geka; 2022 Jan; 50(1):216-221. PubMed ID: 35169101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.
    Zhang X; Xiao W; Zhang Q; Xia D; Gao P; Su J; Yang H; Gao X; Ni W; Lei Y; Gu Y
    Curr Neuropharmacol; 2022; 20(2):292-308. PubMed ID: 34279201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal profile of magnetic resonance angiography and decreased ratio of regulatory T cells after immunological adjuvant administration to mice lacking RNF213, a susceptibility gene for moyamoya disease.
    Kanoke A; Fujimura M; Niizuma K; Fujimura T; Kakizaki A; Ito A; Sakata H; Sato-Maeda M; Kure S; Tominaga T
    Brain Res; 2016 Jul; 1642():1-9. PubMed ID: 26972532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Circulating Factors in Moyamoya Disease.
    Fang YC; Wei LF; Hu CJ; Tu YK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.